THE POLICY EDGE
Policy Bites

3 November 2026

Centre Proposes More Entry Points for Imported Medicines and Medical Devices

An amendment to the Drugs Rules would let importers route consignments through additional inland container depots, a special economic zone and Noida International Airport. The aim is to bring clearance closer to warehouses and manufacturing centres; any improvement in product availability will depend on how the new gateways operate

Policy Bites image

Key Details

The proposed amendment to Rule 43A of the Drugs Rules, 1945 would expand the list of places through which regulated healthcare products may be imported.

Proposed Gateway

Location

Inland container depots (ICDs)

Sonipat, Piyala and Harsaru in Haryana; Dadri in Uttar Pradesh; Gandhidham/Mundra in Gujarat; Sanath Nagar and Thimmapur in Telangana; Whitefield in Karnataka

Special Economic Zone

Bommasandra, Karnataka

International airport

Noida International Airport, Uttar Pradesh, for imports of drugs by air

These would supplement existing authorised gateways, including the ICDs at Dhannad and Tihi in Indore.


More Clearance Options Closer to Healthcare Supply Chains

Rule 43A specifies the entry points through which drugs may be imported into India. The Ministry proposes adding locations across Haryana, Uttar Pradesh, Gujarat, Telangana and Karnataka to give importers more choices about where consignments enter the clearance process.

An inland container depot is a facility away from a seaport where containers can undergo customs-related processing. The Ministry expects the additional locations to let importers clear goods nearer their factories, warehouses and distribution centres, potentially reducing inland transport distances, costs and delays.


Policy Relevance

More gateways could make the movement of imported medicines, medical devices and cosmetics less dependent on existing entry points. The potential benefit for patients is more reliable availability, but the release offers no estimate of how much faster products would reach them.

If the amendment is finalised, that benefit will depend on effective clearance at the additional sites, including coordination between customs and drug regulators. Comparing clearance and delivery times before and after implementation would show whether the change improves supply-chain performance in practice.


Relevant Question for Policy Stakeholders: Which of the proposed gateways have the inspection and clearance capacity needed to move healthcare consignments faster while maintaining existing safety checks?


Follow the Full News Here: Ministry of Health and Family Welfare Proposes Additional Import Gateways

Rethinking Public Policy Through Insight | Inquiry | Impact

Opinion • Grassroots Voices • Policymakers Perspectives • Expert Analysis • Policy Briefs